Sandoz Posts Gain, Due Solely to Fougera

Discussion in 'Nycomed' started by Anonymous, Jan 23, 2013 at 8:33 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    "Sandoz net sales grew 4% (+6% cc) over the prior-year period to USD 2.4 billion. Fougera contributed 7 percentage points of growth from four months of sales reported in the fourth quarter. Excluding Fougera, volume was flat and price had a negative impact of 1 percentage point. Lower enoxaparin sales in the US were partially offset by strong double-digit sales growth in Central and Eastern Europe, Latin America and biosimilars, as well as high single-digit sales in Western Europe and Asia."

    How long before Sandoz turns Fougera into a loser?

    http://finance.yahoo.com/news/novartis-delivers-strong-innovation-2012-060401539.html
     

  2. Anonymous

    Anonymous Guest

    And how long will Sandoz carry PharmaDerm before they dump that dog of a division?
     
  3. Anonymous

    Anonymous Guest

    So now, Fougera is the great white hope? What happened to all the posters that had nothing to say about Fougera except bad things?
     
  4. Anonymous

    Anonymous Guest

    The bad things weren't about Fougera, they were about the leadership. Most of that is gone, except for the crewcut wonder who is now on the Sandoz SLT. How laughable that he is leading pipeline development. We all know how much he did for Fougera....which was NOTHING!
     
  5. Anonymous

    Anonymous Guest

    It seems like either he knows something we don't, or something else is going on. How can someone keep doing that good and so many think he isn't? Something is missing in this picture somehow.
     
  6. Anonymous

    Anonymous Guest

    Pictures! Blackmail or DD was turned on by the weight-lifter pictures!